Table 2 Major adverse cardiac events during follow-up
Event | N (%) | Occurrence delay (months) mean/median ± SD [min–max] |
|---|---|---|
Total MACEs | 44 (37.9%) | 15/17 ± 11.9 [1–51] |
Myocardial infarction (MI) | 30 (25.9%) | 20.5/18 ± 11.9 [2–51] |
Target vessel revascularization (TVR) | 5 (4.3%) | 22.5/24 ± 10.9 [1–51] |
Target lesion revascularization (TLR) | 24 (20.9%) | 20.4/24 ± 11.9 [1–51] |
Deaths | 11 (9.5%) | 22.9/24 ± 10.9 [1–51] |